Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pollen Healthcure is an Indian pharmaceutical company headquartered in Pune, Maharashtra, specializing in the development, manufacturing, and marketing of critical care medicines and life-saving antibiotics. Established in 2015, the company provides a broad portfolio of high-quality, affordable formulations, including carbapenems, glycylcyclines, and polymyxins, primarily targeting intensive care unit (ICU) needs. Their key products include Meropol (meropenem), Tigepol (tigecycline), and Colinex (colistimethate sodium), all produced in GMP and WHO-GMP certified facilities. Beyond pharmaceuticals, Pollen Healthcure offers specialized nutritional supplements under the ICU Pro brand and operates a robust PAN India distribution network with over 200 partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pollen Healthcure.